FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2552214582> ?p ?o ?g. }

• W2552214582 abstract "Abstract Abstract 3572 Poster Board III-509 Strategies using gene-modified hematopoietic stem cells to treat various severe hematopoietic diseases, including but not limited to hemoglobinopathies, will likely require high levels of gene marking. Here we have established efficient and stable in vivo selection in nonhuman primates using methylguanine methyltransferase (MGMTP140K). In the macaque (Macaca nemestrina) we were able to increase pre-chemotherapy lentiviral gene marking levels of 11.3% in granulocytes and 15.3% in lymphocytes to a post-chemotherapy gene marking level of 76.9% in granulocytes and 49.0% in lymphocytes. Furthermore, stable increases in gene marking were also observed in red blood cells (RBCs) and platelets (PLTs) with a pre-chemotherapy gene marking level of 5.6% and 6.7%, respectively, and a post-chemotherapy gene marking level of 15.2% and 64.0%, respectively. Importantly, the chemotherapy regimen was well tolerated, and engraftment was polyclonal as determined by analyzing long-term repopulating clones by LAM-PCR. In order to minimize extra-hematopoietic toxicity we have began to test a more clinically applicable conditioning regimen in the macaque model. This reduced intensity conditioning regimen should allow treatment of patients with severe hematopoietic or infectious diseases, who may not tolerate a high dose conditioning regimen. We tested targeted busulfan for conditioning to provide sufficient myelosuppression and to facilitate engraftment of chemoprotected hematopoietic stem cells while minimizing extra-hematopoietic toxicity. Following conditioning with busulfan (4 mg/kg/day for 2 days) and infusion of gene modified cells (∼1.7 × 107 CD34-selected cells/kg), there was moderate cytopenia with ANC <500/mL for 7 days and thrombocytopenia with a nadir of 18,000/mL. Following stable hematopoietic recovery, we observed gene marking, determined by RT-PCR, in total white blood cells as a provirus copy number of 0.04 (∼4% gene marking) that, following a single cycle of O6BG (x2) and BCNU, rose to 0.16 (∼16% gene marking). Currently, gene marking has been stable for more than 9 months following chemotherapy. The treatment was well tolerated with only transient elevated liver enzymes following O6BG/BCNU treatment and no additional extra-hematopoietic toxicity has been observed. Clonality studies before and after in vivo selection is underway using a combination of LAM-PCR and a modified whole genome pyrosequencing approach. In summary, we have attained efficient and stable in vivo selection of long-term repopulating cells in nonhuman primates, and have extended this approach to use a reduced intensity conditioning regimen that should be well tolerated in patients with many hematopoietic diseases. Disclosures: No relevant conflicts of interest to declare." @default.
• W2552214582 created "2016-11-30" @default.
• W2552214582 creator A5024015738 @default.
• W2552214582 creator A5024123937 @default.
• W2552214582 creator A5060993908 @default.
• W2552214582 creator A5065033882 @default.
• W2552214582 date "2009-11-20" @default.
• W2552214582 modified "2023-10-03" @default.
• W2552214582 title "Efficient MGMTP140K-Mediated In Vivo Selection and Chemoprotection of Long-Term Repopulating Cells in Nonhuman Primates Following Reduced Intensity Conditioning." @default.
• W2552214582 doi "https://doi.org/10.1182/blood.v114.22.3572.3572" @default.
• W2552214582 hasPublicationYear "2009" @default.
• W2552214582 type Work @default.
• W2552214582 sameAs 2552214582 @default.
• W2552214582 citedByCount "0" @default.
• W2552214582 crossrefType "journal-article" @default.
• W2552214582 hasAuthorship W2552214582A5024015738 @default.
• W2552214582 hasAuthorship W2552214582A5024123937 @default.
• W2552214582 hasAuthorship W2552214582A5060993908 @default.
• W2552214582 hasAuthorship W2552214582A5065033882 @default.
• W2552214582 hasConcept C104317684 @default.
• W2552214582 hasConcept C109159458 @default.
• W2552214582 hasConcept C111599444 @default.
• W2552214582 hasConcept C126322002 @default.
• W2552214582 hasConcept C203014093 @default.
• W2552214582 hasConcept C2777408962 @default.
• W2552214582 hasConcept C2780611847 @default.
• W2552214582 hasConcept C28328180 @default.
• W2552214582 hasConcept C502942594 @default.
• W2552214582 hasConcept C54355233 @default.
• W2552214582 hasConcept C71924100 @default.
• W2552214582 hasConcept C86803240 @default.
• W2552214582 hasConceptScore W2552214582C104317684 @default.
• W2552214582 hasConceptScore W2552214582C109159458 @default.
• W2552214582 hasConceptScore W2552214582C111599444 @default.
• W2552214582 hasConceptScore W2552214582C126322002 @default.
• W2552214582 hasConceptScore W2552214582C203014093 @default.
• W2552214582 hasConceptScore W2552214582C2777408962 @default.
• W2552214582 hasConceptScore W2552214582C2780611847 @default.
• W2552214582 hasConceptScore W2552214582C28328180 @default.
• W2552214582 hasConceptScore W2552214582C502942594 @default.
• W2552214582 hasConceptScore W2552214582C54355233 @default.
• W2552214582 hasConceptScore W2552214582C71924100 @default.
• W2552214582 hasConceptScore W2552214582C86803240 @default.
• W2552214582 hasLocation W25522145821 @default.
• W2552214582 hasOpenAccess W2552214582 @default.
• W2552214582 hasPrimaryLocation W25522145821 @default.
• W2552214582 hasRelatedWork W1967750537 @default.
• W2552214582 hasRelatedWork W1968381323 @default.
• W2552214582 hasRelatedWork W1980566831 @default.
• W2552214582 hasRelatedWork W2011119965 @default.
• W2552214582 hasRelatedWork W2027168351 @default.
• W2552214582 hasRelatedWork W2030322847 @default.
• W2552214582 hasRelatedWork W2064457820 @default.
• W2552214582 hasRelatedWork W2071317527 @default.
• W2552214582 hasRelatedWork W2146872389 @default.
• W2552214582 hasRelatedWork W2161314897 @default.
• W2552214582 hasRelatedWork W2424441547 @default.
• W2552214582 hasRelatedWork W2498437243 @default.
• W2552214582 hasRelatedWork W2520632223 @default.
• W2552214582 hasRelatedWork W2529178906 @default.
• W2552214582 hasRelatedWork W2550310769 @default.
• W2552214582 hasRelatedWork W2554829934 @default.
• W2552214582 hasRelatedWork W2575674411 @default.
• W2552214582 hasRelatedWork W2589189769 @default.
• W2552214582 hasRelatedWork W2948621850 @default.
• W2552214582 hasRelatedWork W3100191806 @default.
• W2552214582 isParatext "false" @default.
• W2552214582 isRetracted "false" @default.
• W2552214582 magId "2552214582" @default.
• W2552214582 workType "article" @default.